Gilles VASSAL

Trials

Studies that name Gilles VASSAL as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:03 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT02034981 · Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1

  UNICANCER · completed · Hematologic Cancers, Solid Tumors, Metastatic Cancer · principal investigator
• Ph2
  NCT00180830 · Glivec Phase II Pediatric Study

  Gustave Roussy, Cancer Campus, Grand Paris · terminated · Cancer · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 00:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.